Loading
Latest filing published 15 Aug 2018 for JUNIPER PHARMACEUTICALS INC, €279k.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Nikin Patel appears in our data through filings on Juniper Pharmaceuticals Inc shares, published by SEC (Form 4). We count 15 filings; the first trade dates from 12 September 2013 and the latest from 14 August 2018.
On the market, this insider has only ever bought: 3 purchases, €145k in total. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 6 share grants and 6 option exercises.
A typical purchase (the median) is worth €48k.
The latest filing, published on 15 August 2018, reports an option exercise of €279k in Juniper Pharmaceuticals Inc. The last insider purchase was made public on 20 November 2015, 3,990 days ago. The median gap between a trade and its publication by SEC (Form 4) is 1 day. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
15 of 15 declarations